Cargando…
Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine
With advances in the discovery of the clinical and molecular landscapes of prostate cancer (PCa), implementation of precision medicine-guided therapeutic testing in the clinic has become a priority. Patient derived organoids (PDOs) are three-dimensional (3D) tissue cultures that promise to enable th...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480086/ https://www.ncbi.nlm.nih.gov/pubmed/34587953 http://dx.doi.org/10.1186/s12943-021-01426-3 |